Green Cross Corp Cash Flow Conversion Efficiency
Green Cross Corp cash flow conversion efficiency. Based on the latest financial reports, Green Cross Corp (006280) has a cash flow conversion efficiency ratio of 0.094x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩139.65 Billion ≈ $94.64 Million USD) by net assets (₩1.49 Trillion ≈ $1.01 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Green Cross Corp (2004–2024)
Cash flow conversion efficiency of Green Cross Corp from 2004 to 2024. This chart illustrates how Green Cross Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Green Cross Corp stock quote for real-time trading data and today's change.
Green Cross Corp Cash Flow Conversion Ratio Explained
Green Cross Corp cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Green Cross Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Green Cross Corp ranked by their cash flow conversion efficiency. Also see Green Cross Corp (006280) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guanglian Aviation Industry Co Ltd
SHE:300900
|
-0.011x |
|
Bank Pan Indonesia Tbk
JK:PNBN
|
0.007x |
|
Guangxi Liuzhou Pharm Co Ltd
SHG:603368
|
0.006x |
|
MYT Netherlands Parent BV
NYSE:MYTE
|
0.045x |
|
HNA Technology Co Ltd A
SHG:600751
|
0.011x |
|
Aerosun Corp
SHG:600501
|
0.127x |
|
Zhejiang Songyuan Automotive Safety
SHE:300893
|
0.019x |
|
Paradise Co. Ltd
KQ:034230
|
0.028x |
Annual Cash Flow Conversion Efficiency for Green Cross Corp (2004–2024)
The table below shows the annual cash flow conversion efficiency of Green Cross Corp from 2004 to 2024. Review how much free cash does Green Cross Corp generate to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩1.48 Trillion ≈ $1.00 Billion |
₩-53.46 Billion ≈ $-36.23 Million |
-0.036x | -915.64% |
| 2023-12-31 | ₩1.54 Trillion ≈ $1.04 Billion |
₩-5.47 Billion ≈ $-3.71 Million |
-0.004x | -104.67% |
| 2022-12-31 | ₩1.57 Trillion ≈ $1.06 Billion |
₩119.15 Billion ≈ $80.75 Million |
0.076x | -9.46% |
| 2021-12-31 | ₩1.50 Trillion ≈ $1.02 Billion |
₩125.98 Billion ≈ $85.37 Million |
0.084x | +196.39% |
| 2020-12-31 | ₩1.27 Trillion ≈ $860.19 Million |
₩35.97 Billion ≈ $24.38 Million |
0.028x | -16.71% |
| 2019-12-31 | ₩1.18 Trillion ≈ $802.43 Million |
₩40.29 Billion ≈ $27.30 Million |
0.034x | +165.94% |
| 2018-12-31 | ₩1.13 Trillion ≈ $763.21 Million |
₩14.41 Billion ≈ $9.77 Million |
0.013x | -75.49% |
| 2017-12-31 | ₩1.11 Trillion ≈ $751.36 Million |
₩57.88 Billion ≈ $39.22 Million |
0.052x | +3273.10% |
| 2016-12-31 | ₩1.06 Trillion ≈ $717.68 Million |
₩-1.74 Billion ≈ $-1.18 Million |
-0.002x | -103.63% |
| 2015-12-31 | ₩997.70 Billion ≈ $676.13 Million |
₩45.24 Billion ≈ $30.66 Million |
0.045x | -26.45% |
| 2014-12-31 | ₩920.63 Billion ≈ $623.90 Million |
₩56.76 Billion ≈ $38.47 Million |
0.062x | +74.32% |
| 2013-12-31 | ₩839.41 Billion ≈ $568.86 Million |
₩29.69 Billion ≈ $20.12 Million |
0.035x | -52.25% |
| 2012-12-31 | ₩685.23 Billion ≈ $464.37 Million |
₩50.76 Billion ≈ $34.40 Million |
0.074x | -14.89% |
| 2011-12-31 | ₩630.28 Billion ≈ $427.13 Million |
₩54.86 Billion ≈ $37.17 Million |
0.087x | -44.13% |
| 2010-12-31 | ₩542.23 Billion ≈ $367.46 Million |
₩84.47 Billion ≈ $57.25 Million |
0.156x | +6.04% |
| 2006-12-31 | ₩185.98 Billion ≈ $126.03 Million |
₩27.32 Billion ≈ $18.52 Million |
0.147x | -8.02% |
| 2005-12-31 | ₩145.70 Billion ≈ $98.74 Million |
₩23.27 Billion ≈ $15.77 Million |
0.160x | +6.53% |
| 2004-12-31 | ₩108.95 Billion ≈ $73.83 Million |
₩16.34 Billion ≈ $11.07 Million |
0.150x | -- |
About Green Cross Corp
GC Biopharma Corp., a biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally. It provides over-the-counter drugs, such as Acustop Cataplasma for Analgesic and anti-inflammatory effect; Kenhancer plaster for anti-inflammatory; and Zenol Cool Type and Zenol Mild Hot Type drugs to treat anti-inflammatory and pain relief. The company also offers Albumin-… Read more